This tool streamlines real-world data feasibility assessments by giving fast, cost-effective access to global datasets. Users can self-serve via an AI-powered cohort builder or request expert support to analyze drug use, conditions, and procedures. Features include advanced inclusion/exclusion criteria, seamless transition into deeper analytics, rapid patient cohort development, and flexible delivery options. The AI engine accelerates cohort definition with smart suggestions, enabling faster insights, collaboration, and cross-country analysis.

Join for free to read